A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

Completed · Phase 2 · Has a placebo group

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to evaluate the safety and efficacy of IDP-107 versus placebo in treating patients with acne vulgaris.

Key facts

Study ID

NCT01194375

Run by

Dow Pharmaceutical Sciences

People needed

180

Starts

2010-09-01

Expected to finish

2011-12-01

Last updated by the study team

2012-07-02

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presence of acne vulgaris on the face and neck/trunk
• Presence of inflammatory and non-inflammatory lesions on the face

You may not qualify if…

• Presence of any skin condition on the face that could interfere with clinical evaluations
• Use of any systemic antibiotics or corticosteroids within 4 weeks prior to the Baseline visit
• Use of any systemic retinoids, such as isotretinoin, within 3 months prior to the Baseline visit
• Woman who is pregnant, nursing an infant, or planning a pregnancy during the study period

Where it is running

• Dermatology Specialists, Inc. — Oceanside, California, United States
• Horizons Clinical Research Center, LLC — Denver, Colorado, United States
• North Florida Dermatology Associates, PA — Jacksonville, Florida, United States
• FXM Research Corp. — Miami, Florida, United States
• Ameriderm Research — Ormond Beach, Florida, United States
• Dawes Fretzin Clinical Research Group, LLC — Indianapolis, Indiana, United States
• The Indiana Clinical Trials Center, PC — Plainfield, Indiana, United States
• Pedia Research LLC — Owensboro, Kentucky, United States
• ActivMed Practices and Research, Inc. — Haverhill, Massachusetts, United States
• Hamzavi Dermatology — Fort Gratiot, Michigan, United States
• Minnesota Clinical Study Center — Fridley, Minnesota, United States
• Comprehensive Clinical Research — Berlin, New Jersey, United States
• Oregon Dermatology and Research Center — Portland, Oregon, United States
• DermResearch, Inc. — Austin, Texas, United States
• Dermatology Research Center, Inc. — Salt Lake City, Utah, United States
• South Valley Dermatology — West Jordan, Utah, United States
• Premier Clinical Research — Spokane, Washington, United States
• Ultranova Skincare — Barrie, Ontario, Canada
• The Centre for Dermatology and Cosmetic Surgery — Richmond Hill, Ontario, Canada
• K. Papp Clinical Research — Waterloo, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.